European Journal of Cancer
Volume 46, Issue 16 , Pages 3016-3021 , November 2010

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation

  • Maja J.A. de Jonge

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • Authors contributed equally.
    • Corresponding Author InformationCorresponding author: Tel.: +31 10 439 1760; fax: +31 10 439 1003.
    • ,
  • Marije Slingerland

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands
    • Authors contributed equally.
    • ,
  • Walter J. Loos

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Erik A.C. Wiemer

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Herman Burger

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Ron H.J. Mathijssen

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Judith R. Kroep

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands
    • ,
  • Margret A.G. den Hollander

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands
    • ,
  • Diane van der Biessen

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Mei-Ho Lam

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Jaap Verweij

      Affiliations

    • Erasmus University Medical Center Daniel Den Hoed Cancer Center, Department of Medical Oncology, Rotterdam, The Netherlands
    • ,
  • Hans Gelderblom

      Affiliations

    • Leiden University Medical Center, Department of Clinical Oncology, Leiden, The Netherlands

Received 31 May 2010 ,Accepted 14 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This clinical trial was registered as EUDRACT 2006-006637-40.

PII: S0959-8049(10)00693-3

doi: 10.1016/j.ejca.2010.07.015

European Journal of Cancer
Volume 46, Issue 16 , Pages 3016-3021 , November 2010

Article Tools

* Image Usage & Resolution